alexa
Reach Us +44-1647-403003
Could Serum Testosteron Level and Body Mass Index Predict Psa Relaps in Prostate Cancer Patients undergoing Radical Surgery? | OMICS International | Abstract
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Could Serum Testosteron Level and Body Mass Index Predict Psa Relaps in Prostate Cancer Patients undergoing Radical Surgery?

Adnan Simsir, Cag Cal*, Rashad Mammadov, Ibrahim Cureklibatir and Gurhan Gunaydin

Ege University School of Medicine, Department of Urology, Izmir, Turkey

*Corresponding Author:
Adnan Simsir
EÜTF Hastanesi 4. kat Üroloji AD
Bornova Izmir, Turkey
Tel: +90 232 390 25 17
Fax: +90 533 3364354
E-mail: [email protected]

Received Date: October 06, 2011; Accepted Date: November 17, 2011; Published Date: November 19, 2011

Citation: Simsir A, Cal C, Mammadov R, Cureklibatir I, Gunaydin G (2011) Could Serum Testosteron Level and Body Mass Index Predict Psa Relaps in Prostate Cancer Patients undergoing Radical Surgery? J Cancer Sci Ther S1:007. doi: 10.4172/1948-5956.S1-007

Copyright: © 2011 Simsir A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Purpose: It is well-known that indicators such as biopsy and prostatectomy Gleason score , clinical and pathological stage and preoperative PSA level can be utilized in predicting PSA recurrence in cases who underwent radical prostatectomy (RP) with the diagnosis of organ-confined prostate cancer. The purpose of this study was to investigate the predictability of postoperative PSA recurrence by serum total testosterone levels as well as body mass index (BMI).

Materials and methods: Fourty-eight patients in whom RP was planned with the diagnosis of prostate-confined cancer were enrolled in this study. The data recorded included the patient’s preoperative testosterone levels and BMI as well as age, serum PSA level, clinical stage, Gleason score on biopsy, the presence of PIN and surgical margin positivity. After operation, the patients were kept under follow up according to the guidelines. During the follow-up, the analysis of the selected markers was performed using T-test, Mann-Whitney U test, Chi square test, Anova and Roc analysis in cases with documented PSA recurrence.

Results: Serum total testosterone level, BMI, surgical margin positivity and Gleason score and preoperative PSA level are independent variables that affect PSA recurrence. On Roc analysis, a testosterone level of less than 2,81 ng/dL was found to be significant for the prediction of PSA recurrence (p=0.04).

Conclusion: From this study, we concluded that, besides proven risk factors for PSA recurrence (Pre op. PSA level, Gleason score, surgical margin positivity and stage), preoperative low testosterone levels and high BMI can also be predictive.

Keywords

Top